Anzeige
Mehr »
Mittwoch, 26.11.2025 - Börsentäglich über 12.000 News
Kupfer-Superzyklus voraus: Dieses Top-Projekt in Nevada wird jetzt zum echten Investmentcase
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Frankfurt
26.11.25 | 08:14
3,010 Euro
+3,26 % +0,095
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
3,0503,13020:14

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiMedian Technologies to Showcase AI-Powered Software as a Medical Device eyonis LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting232Peer-reviewed scientific presentation: "Rethinking Lung Cancer Screening: Longitudinal AI/ML Diagnostics beyond Nodule Size Growth" AI Theater Presentation: "eyonis LCS: Transforming Lung...
► Artikel lesen
13.11.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2025225Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.11.Lion Point Capital founder joins Median Technologies board3
03.11.Median Technologies Appoints Didric Cederholm to Its Board of Directors232Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software...
► Artikel lesen
28.10.Median Technologies: €19 Million EIB Financing Raised To Boost AI-Enabled Cancer Diagnosis Platform2
23.10.Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results328Operating loss reduced by €4 million in first six months of 2025 versus H1 2024, highlighting improved corporate efficiency H1 2025 revenues at €11.3 million, vs €10.9 million in H1 2024...
► Artikel lesen
21.10.Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility295Proceeds to support the commercial launch of eyonis®LCS in the U.S. and Europe, and accelerate the broader development of eyonis®, Median's AI-powered Software as a Medical Device suite for early...
► Artikel lesen
13.10.Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Ordinary and Extraordinary General Meeting on October 31, 2025230Regulatory News: The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Ordinary and Extraordinary...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
06.10.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2025234Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatoy News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
22.09.Median Technologies Business Update Following Successful Financing276Cash runway extended until at least Q4 2026 and potentially well beyond eyonis® LCS commercial launch preparations underway in the U.S. eyonis® LCS subject to advanced negotiations...
► Artikel lesen
08.09.Median Technologies: H2 2025 Financial Communication Calendar303Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company")manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
04.09.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025269Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
07.08.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2025303Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
01.08.Median Technologies Has Completed a Capital Increase of € 23.9 Million531Capital increase of 23.9 million euros from institutional and retail investors at a subscription price of €1.66 per ABSA Extension of the Company's cash runway until Q4 2026 Regulatory...
► Artikel lesen
23.07.Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies launches an approximately €22 million capital increase to support commercialization of eyonis LCS in the U.S. ...638Capital increase in the form of shares with attached warrants ("ABSA") without preferential subscription rights by way of an equity public offering and with a priority subscription period of 5...
► Artikel lesen
11.07.Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB)550Regulatory News: Median Technologies FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
09.07.Median Technologies: Half Year Liquidity Contract Statement350Regulatory News: Under the liquidity contract entrusted by Median Technologies (PARIS: ALMDT, FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following...
► Artikel lesen
07.07.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2025295Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
01.07.Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis LCS385Class IIb CE marking is a prerequisite for Median's eyonis LCS Software as a Medical Device marketing in Europe Lung cancer screening programs are already implemented in several European...
► Artikel lesen
10.06.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2025340Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1